Trial Profile
Safety of Autologous Adipose Derived Mesenchymal Stem Cells in Patients With Spinal Cord Injury
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Stem cell therapies (Primary)
- Indications Spinal cord injuries
- Focus Adverse reactions
- Acronyms Astrostem
- Sponsors K-STEMCELL
- 02 Dec 2014 New trial record